AC
CC icon

AlphaCore Capital’s Chemours CC Stock Holding History

AlphaCore Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed – – 108
2020
Q1 		$0 Buy
+2
New +$29 ﹤0.01% 336

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AlphaCore Capital's CC Position: Q2 2020 in Review

AlphaCore Capital sold out of Chemours (CC) in Q2 2020, closing a stake of 2 shares.

AlphaCore Capital first reported a position in CC in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 396 funds tracked by Wall St. Rank hold CC as of Q2 2020.

  • AlphaCore Capital reported no remaining Chemours position as of Q2 2020 after selling out during the quarter.
  • AlphaCore Capital sold 2 Chemours shares in Q2 2020.
  • AlphaCore Capital first reported a position in Chemours in Q1 2020 and held it in 1 quarter.
  • AlphaCore Capital's Chemours position peaked at $0 in Q1 2020.
  • 396 funds tracked by Wall St. Rank held Chemours as of Q2 2020.

Based on AlphaCore Capital's 13F filing for Q2 2020, filed 14 Aug 2020.